Literature DB >> 34306502

An analysis of clinical values of MRI, CT and X-ray in differentiating benign and malignant bone metastases.

Chun Xiong1, Xian Xu2, Huiling Zhang3, Bo Zeng4.   

Abstract

OBJECTIVE: To investigate the clinical values of magnetic resonance imaging (MRI), computed tomography (CT) and X-ray in differential diagnosis of benign and malignant bone metastases.
METHODS: A total of 80 patients with bone metastases admitted to our hospital were selected as the study subjects. X-ray, CT and MRI examinations were performed, respectively. The pathological examination results were taken as the gold standard to analyze the lesion sites of metastatic tumors in 80 subjects. The diagnostic sensitivity, specificity and accuracy of X-ray, CT and MRI examinations were calculated and compared.
RESULTS: Among the 80 patients, 71 cases were diagnosed as malignant bone metastases and 9 cases as benign lesions according to pathological examination. The diagnostic sensitivity, specificity and accuracy of X-ray, CT and MRI examinations were 63.38%, 33.33% and 60.00%, 84.51%, 66.67% and 82.50%, and 90.14%, 77.78% and 88.75%, respectively. MRI was superior to X-ray in the sensitivity, specificity and accuracy of differential diagnosis of benign and malignant bone metastases (P < 0.05). MRI was superior to CT, but there was no significant difference between the two groups (P < 0.05). The diagnostic sensitivity, specificity and accuracy of CT + MRI were significantly higher than those of any single detection method (P < 0.05).
CONCLUSION: MRI, CT and X-ray exhibit a good value in differential diagnosis of benign and malignant bone metastases. Overall, MRI is superior to CT and X-ray in the screening effects, and the combined detection methods are more satisfactory. It is recommended that CT should be used for primary screening, and CT + MRI should be implemented for a enhanced diagnosis. AJTR
Copyright © 2021.

Entities:  

Keywords:  CT; MRI; X-ray; analysis; bone metastases; clinical values; differentiation between benign and malignant tumors

Year:  2021        PMID: 34306502      PMCID: PMC8290716     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  26 in total

Review 1.  [Treatment of bone metastases: bisphosphonates and denosumab].

Authors:  László Landherr; Tamás Nagykálnai
Journal:  Magy Onkol       Date:  2016-07-23

2.  Thyroid cancer-related bone metastases: increasingly good prospects for treatment.

Authors:  Leonidas H Duntas
Journal:  Endocrine       Date:  2018-05-19       Impact factor: 3.633

3.  Palliative radiotherapy, bone metastases, and global assessments in palliative care.

Authors:  Charles B Simone
Journal:  Ann Palliat Med       Date:  2017-08-23

4.  Molecular imaging of bone metastases using bone targeted tracers.

Authors:  Sofia Vaz; Sharjeel Usmani; Gopinath Gnanasegaran; Tim Van den Wyngaert
Journal:  Q J Nucl Med Mol Imaging       Date:  2019-07-08       Impact factor: 2.346

Review 5.  Molecular Imaging of Bone Metastases and Their Response to Therapy.

Authors:  Gary J R Cook; Vicky Goh
Journal:  J Nucl Med       Date:  2020-04-03       Impact factor: 10.057

Review 6.  Translational models of prostate cancer bone metastasis.

Authors:  Richard B Berish; Aymon N Ali; Patrick G Telmer; John A Ronald; Hon S Leong
Journal:  Nat Rev Urol       Date:  2018-07       Impact factor: 14.432

7.  Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers.

Authors:  Lauriane Chambard; Nicolas Girard; Edouard Ollier; Jean-Charles Rousseau; François Duboeuf; Marie-Christine Carlier; Marie Brevet; Pawel Szulc; Jean-Baptiste Pialat; Julien Wegrzyn; Philippe Clezardin; Cyrille B Confavreux
Journal:  Bone       Date:  2018-01-11       Impact factor: 4.398

Review 8.  Molecular Mechanisms of Bone Metastasis.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwendlyn Kollmorgen; Rüdiger Rüger
Journal:  Cancer Genomics Proteomics       Date:  2016 Jan-Feb       Impact factor: 4.069

Review 9.  Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment.

Authors:  Gary J R Cook; Gurdip K Azad; Vicky Goh
Journal:  J Nucl Med       Date:  2016-02       Impact factor: 10.057

10.  Clinical Characteristics and Prognostic Factors in Bone Metastases from Lung Cancer.

Authors:  Li Zhang; Zhixin Gong
Journal:  Med Sci Monit       Date:  2017-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.